PartnerRe Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,282
Closed -$133K 424
2016
Q1
$133K Buy
1,282
+103
+9% +$9.96K 0.07% 225
2015
Q4
$117K Sell
1,179
-2,006
-63% -$196K 0.06% 248
2015
Q3
$290K Buy
3,185
+15
+0.5% +$1.5K 0.05% 271
2015
Q2
$336K Sell
3,170
-545
-15% -$60.3K 0.06% 255
2015
Q1
$424K Hold
3,715
0.07% 245
2014
Q4
$409K Buy
3,715
+529
+17% +$55.8K 0.07% 252
2014
Q3
$311K Sell
3,186
-489
-13% -$48.1K 0.06% 260
2014
Q2
$371K Sell
3,675
-540
-13% -$52.7K 0.07% 255
2014
Q1
$387K Sell
4,215
-24
-0.6% -$2.21K 0.06% 272
2013
Q4
$384K Sell
4,239
-212
-5% -$18.3K 0.07% 267
2013
Q3
$355K Sell
4,451
-553
-11% -$43.5K 0.06% 286
2013
Q2
$364K Buy
+5,004
New +$374K 0.06% 291

Other funds holding ZBH

PartnerRe Asset Management's ZBH Position: Q2 2016 in Review

PartnerRe Asset Management sold out of Zimmer Biomet (ZBH) in Q2 2016, closing a stake of 1,282 shares — an estimated $133K sold.

PartnerRe Asset Management first reported a position in ZBH in Q2 2013 and held it in 12 quarters. The position peaked at $424K in Q1 2015. 765 funds tracked by Wall St. Rank hold ZBH as of Q2 2016.

  • PartnerRe Asset Management reported no remaining Zimmer Biomet position as of Q2 2016 after selling out during the quarter.
  • PartnerRe Asset Management sold 1,282 Zimmer Biomet shares in Q2 2016, an estimated $133K.
  • PartnerRe Asset Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 12 quarters.
  • PartnerRe Asset Management's Zimmer Biomet position peaked at $424K in Q1 2015.
  • 765 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2016.

Based on PartnerRe Asset Management's 13F filing for Q2 2016, filed 14 Jul 2016.